Home/Pipeline/Exome Sequencing with Patient for Life™

Exome Sequencing with Patient for Life™

Rare Disease Diagnosis

CommercialActive

Key Facts

Indication

Rare Disease Diagnosis

Phase

Commercial

Status

Active

Company

Ambry Genetics

About Ambry Genetics

Ambry Genetics is a leading, well-established clinical genetic testing laboratory with a 25-year history. Its core business focuses on diagnostic services for hereditary cancer and rare diseases, leveraging proprietary technologies like +RNAinsight™ and the Patient for Life™ reanalysis program to improve diagnostic yield and accuracy. The company operates a services-based business model, generating revenue from test fees, and has processed over one million tests, demonstrating significant market adoption. Ambry emphasizes scientific rigor, participates in landmark research, and offers digital health tools like the Ambry CARE Program® to identify at-risk patients.

View full company profile

Therapeutic Areas

Hereditary Cancer Rare Disease Hereditary Cardiovascular Disease Neurodevelopmental Disorders Epilepsy

Other Rare Disease Diagnosis Drugs

Drug	Company	Phase	Status
Rare Disease Genome	MyOme	Commercial	Active
Rare Disease Exome	MyOme	Commercial	Active
Zenith™ Genomics	Natera	Commercial Launch	Active